Advertisement

Topics

Search Results for "Psa Increased After Negative Biopsy"

12:24 EST 9th December 2016 | BioPortfolio

Matching Channels

Matching News

Guidelines developed for prostate MRI after negative biopsy

(HealthDay)—In a consensus statement from the American Urological Association and Society of Abdominal Radiology, published in the December issue of The Journal of Urology, guidelines are presented ...

How should patients be monitored for prostate cancer after a negative biopsy?

(Elsevier Health Sciences) An expert panel of urologists and radiologists from the American Urological Association (AUA) and the Society of Abdominal Radiology (SAR) has published a set of consensus s...

Make the Diagnosis: Lesion Decision

(MedPage Today) -- Case Findings: A 39-year-old female presents with a back lesion (depicted below) observed during a physical examination when the patient was seen for a chronic cough. Upon biopsy, t...

Biopsy Devices Current and Future Players Prices from USD $3500

Biopsy Devices Current and Future PlayersSummaryCancer is the uncontrolled growth of abnormal cells in the body. It can either spread to neighboring tissues or remain localized. When a patient is sus...

Precision Biopsy expands clinical trial of ClariCore biopsy system to include prostate cancer patients

Precision Biopsy announced that its application for an Investigational Device Exemption (IDE) was approved by the U.S. Food and Drug Administration (FDA), allowing the company to expand its clinical t...

Biopsy Devices US Analysis and Market Forecasts Prices from USD $4450

Biopsy Devices US Analysis and Market ForecastsSummaryCancer is the uncontrolled growth of abnormal cells in the body. It can either spread to neighboring tissues or remain localized. When a patient ...

MediPoint: Biopsy Devices Global Analysis and Market Forecasts Prices from USD $5995

MediPoint: Biopsy Devices Global Analysis and Market ForecastsSummaryCancer is the uncontrolled growth of abnormal cells in the body. It can either spread to neighboring tissues or remain localized. ...

Prostate Cancer: Informed Decisions or Information Overload?

(MedPage Today) -- To biopsy, or not to biopsy -- a Shakespearean dilemma

Matching PubMed Articles

Management of men with previous negative prostate biopsy.

Up to 70% of prostate biopsies are negative in men with suspected prostate cancer. Because of inherent limitations in biopsy strategies, a significant proportion of cancers are missed on initial biops...

Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results.

The purpose of this study was to evaluate the prostate cancer yield rate of targeted transrectal ultrasound (TRUS)-guided biopsy with cognitive magnetic resonance imaging (MRI) registration without co...

Predictive Value of Negative 3T Multiparametric Prostate MRI on 12 Core Biopsy Results.

To evaluate the cancer detection rates (CDR) for men undergoing 12 core systematic prostate biopsy with negative prebiopsy mpMRI (NegMR).

Multiple biopsy passes and the risk of complications of percutaneous liver biopsy.

To minimize the sample variability of liver biopsy, the tissue length should be at least 25 mm. Consequently, more than one biopsy pass is needed with cutting biopsy needles. We aimed to investigate...

Patterns of clinical practice for sentinel lymph node biopsy in women with node-negative breast cancer: the results of a national survey in Japan.

Sentinel lymph node (SLN) biopsy is now accepted as the standard of care for axillary staging in women with node-negative breast cancer. Currently, dye, radioisotope (RI), and fluorescence indocyanine...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement